97 related articles for article (PubMed ID: 24195527)
1. Discussion: session 1.
Sehouli J; del Campo JM; Lorusso D
Future Oncol; 2013 Dec; 9(12 Suppl):25-7. PubMed ID: 24195527
[No Abstract] [Full Text] [Related]
2. Editorial comment to Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.
Miyake H; Fujisawa M
Int J Urol; 2015 Mar; 22(3):293. PubMed ID: 25422037
[No Abstract] [Full Text] [Related]
3. Salvage chemotherapy for refractory germ cell tumors.
Dorff TB; Hu JS; Quinn DI
Oncology (Williston Park); 2014 Jun; 28(6):498-500. PubMed ID: 25134324
[No Abstract] [Full Text] [Related]
4. Ovarian cancer: optimal chemotherapy in relapsed disease.
Conte PF; Cianci C; Tanganelli L; Gadducci A
Ann Oncol; 2000; 11 Suppl 3():145-50. PubMed ID: 11079132
[No Abstract] [Full Text] [Related]
5. Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients.
Gaviani P; Salmaggi A; Silvani A
J Neurooncol; 2011 Sep; 104(2):617-8. PubMed ID: 21229293
[No Abstract] [Full Text] [Related]
6. Emerging role for bevacizumab in combination with chemotherapy for patients with platinum-resistant ovarian cancer.
Liu JF; Cannistra SA
J Clin Oncol; 2014 May; 32(13):1287-9. PubMed ID: 24637996
[No Abstract] [Full Text] [Related]
7. Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma.
Beddoe AM; Dottino PR; Cohen CJ
Mt Sinai J Med; 1993 Sep; 60(4):311-6. PubMed ID: 8232377
[TBL] [Abstract][Full Text] [Related]
8. Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial.
Tomao F; Tomao S; Benedetti Panici P
J Clin Oncol; 2014 Nov; 32(31):3580. PubMed ID: 25185105
[No Abstract] [Full Text] [Related]
9. Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?
Seiter K
Leuk Res; 2016 Feb; 41():1-2. PubMed ID: 26764223
[No Abstract] [Full Text] [Related]
10. Second-line treatment and consolidation therapies in advanced ovarian cancer.
Conte PF; Gadducci A; Cianci C
Int J Gynecol Cancer; 2001; 11 Suppl 1():52-6. PubMed ID: 11489004
[No Abstract] [Full Text] [Related]
11. [Standard of chemotherapy in ovarian cancer].
Pfleiderer A; Meerpohl HG
Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
[No Abstract] [Full Text] [Related]
12. Chemotherapy of ovarian cancer.
Ozols RF; Young RC
Semin Oncol; 1991 Jun; 18(3):222-32. PubMed ID: 2042062
[No Abstract] [Full Text] [Related]
13. Reply to F. Tomao et al.
Pujade-Lauraine E; Hilpert F; Poveda A
J Clin Oncol; 2014 Nov; 32(31):3580. PubMed ID: 25185088
[No Abstract] [Full Text] [Related]
14. Does intraperitoneal therapy have a role in recurrent ovarian cancer?
Cain JM
World J Surg; 2007 Sep; 31(9):1821. PubMed ID: 17623233
[No Abstract] [Full Text] [Related]
15. Treatment of recurrent ovarian cancer: increasing options--"recurrent" results.
Ozols RF
J Clin Oncol; 1997 Jun; 15(6):2177-80. PubMed ID: 9196128
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of a second instance of carcinoma of the ovary].
Giaccone G; Clerico M; Donadio M; Calciati A
Minerva Ginecol; 1984 Apr; 36(4):209-12. PubMed ID: 6462524
[No Abstract] [Full Text] [Related]
17. ICON-6: the danger of changing study design midstream.
Norrie J
Lancet; 2016 Mar; 387(10023):1031-1032. PubMed ID: 27025174
[No Abstract] [Full Text] [Related]
18. Treatment for recurrent ovarian cancer. A report of 2 cases.
Maxwell AM; Jordaan JP
S Afr Med J; 1987 Feb; 71(3):180. PubMed ID: 3810370
[TBL] [Abstract][Full Text] [Related]
19. A unique role for retrospective studies in clinical oncology.
Markman M
Oncology; 2014; 86(5-6):350. PubMed ID: 24942408
[No Abstract] [Full Text] [Related]
20. Salvage treatment of ovarian cancer.
Muggia FM
J Clin Oncol; 1997 Nov; 15(11):3420-1. PubMed ID: 9363877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
